Autophagy Modulation as a Treatment of Amyloid Diseases

Autophagy Modulation as a Treatment of Amyloid Diseases

Amyloids are fibrous proteins aggregated into toxic forms that are implicated in several chronic disorders. More than 30 diseases show deposition of fibrous amyloid proteins associated with cell loss and degeneration in the affected tissues. Evidence demonstrates that amyloid diseases result from pr...

Full description

Bibliographic Details
Main Authors:	Zoe Mputhia, Eugene Hone, Timir Tripathi, Tim Sargeant, Ralph Martins, Prashant Bharadwaj
Format:	Article
Language:	English
Published:	MDPI AG 2019-09-01
Series:	Molecules
Subjects:	amyloid autophagy clearance toxicity lysosome Alzheimer’s disease Parkinson’s disease polyglutamine Tau protein beta amyloid α-synuclein Huntington’s disease
Online Access:	https://www.mdpi.com/1420-3049/24/18/3372

Similar Items

Activate or Inhibit? Implications of Autophagy Modulation as a Therapeutic Strategy for Alzheimer’s Disease
by: Sharmeelavathi Krishnan, et al.
Published: (2020-09-01)

Autophagy and Alzheimer’s Disease: From Molecular Mechanisms to Therapeutic Implications
by: Md. Sahab Uddin, et al.
Published: (2018-01-01)

Implications of the Orb2 Amyloid Structure in Huntington’s Disease
by: Rubén Hervás, et al.
Published: (2020-09-01)

Pathologic polyglutamine aggregation begins with a self-poisoning polymer crystal
by: Tej Kandola, et al.
Published: (2023-11-01)

Parkinson’s Disease Dementia: Synergistic Effects of Alpha-Synuclein, Tau, Beta-Amyloid, and Iron
by: Jiajun Han, et al.
Published: (2021-10-01)

The Strategies of Development of New Non-Toxic Inhibitors of Amyloid Formation
by: Oxana V. Galzitskaya, et al.
Published: (2023-02-01)

Impairment of the autophagy–lysosomal pathway in Alzheimer's diseases: Pathogenic mechanisms and therapeutic potential
by: Wei Zhang, et al.
Published: (2022-03-01)

The role of autophagy in Alzheimer's disease and its potential for therapy
by: Min LIU, et al.
Published: (2014-05-01)

Brain clearance of protein aggregates: a close-up on astrocytes
by: Veronica Giusti, et al.
Published: (2024-01-01)

Distinctive alteration in the expression of autophagy genes in Drosophila models of amyloidopathy and tauopathy
by: Mehrnaz Haghi, et al.
Published: (2020-10-01)

The emerging role of the first 17 amino acids of huntingtin in Huntington’s disease
by: Arndt James R., et al.
Published: (2015-03-01)

Photo-Oxygenation as a New Therapeutic Strategy for Neurodegenerative Proteinopathies by Enhancing the Clearance of Amyloid Proteins
by: Ikumi Tomizawa, et al.
Published: (2022-06-01)

Longitudinal Alterations of Alpha-Synuclein, Amyloid Beta, Total, and Phosphorylated Tau in Cerebrospinal Fluid and Correlations Between Their Changes in Parkinson's Disease
by: Mahsa Dolatshahi, et al.
Published: (2018-07-01)

Salivary levels of disease-related biomarkers in the early stages of Parkinson’s and Alzheimer’s disease: A cross-sectional study
by: Masoomeh Sabaei, et al.
Published: (2023-06-01)

Alpha-synuclein: a pathological factor with Aβ and tau and biomarker in Alzheimer’s disease
by: Kyu Hwan Shim, et al.
Published: (2022-12-01)

Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer’s Disease
by: P. Hemachandra Reddy, et al.
Published: (2019-05-01)

Protein Aggregation and Dysfunction of Autophagy-Lysosomal Pathway: A Vicious Cycle in Lysosomal Storage Diseases
by: Antonio Monaco, et al.
Published: (2020-03-01)

New Pathways Identify Novel Drug Targets for the Prevention and Treatment of Alzheimer’s Disease
by: Botond Penke, et al.
Published: (2023-03-01)

Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer’s disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study
by: Caterina Motta, et al.
Published: (2023-08-01)

Promiscuous Roles of Autophagy and Proteasome in Neurodegenerative Proteinopathies
by: Fiona Limanaqi, et al.
Published: (2020-04-01)

α-Synuclein Heterocomplexes with β-Amyloid Are Increased in Red Blood Cells of Parkinson’s Disease Patients and Correlate with Disease Severity
by: Simona Daniele, et al.
Published: (2018-02-01)

Functional genomic analyses uncover APOE-mediated regulation of brain and cerebrospinal fluid beta-amyloid levels in Parkinson disease
by: Laura Ibanez, et al.
Published: (2020-11-01)

Peptide-Based Vaccines for Neurodegenerative Diseases: Recent Endeavors and Future Perspectives
by: Vyronia Vassilakopoulou, et al.
Published: (2021-11-01)

Secondary Nucleation and the Conservation of Structural Characteristics of Amyloid Fibril Strains
by: Saeid Hadi Alijanvand, et al.
Published: (2021-04-01)

Re-Arranging the Puzzle between the Amyloid-Beta and Tau Pathology: An APP-Centric Approach
by: Florence Haut, et al.
Published: (2023-12-01)

Potential of Sorghum Polyphenols to Prevent and Treat Alzheimer’s Disease: A Review Article
by: Nasim Rezaee, et al.
Published: (2021-10-01)

Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau
by: Niklas Mattsson‐Carlgren, et al.
Published: (2021-06-01)

The role of amyloid beta clearance in cerebral amyloid angiopathy: more potential therapeutic targets
by: Xue-mei Qi, et al.
Published: (2017-08-01)

Linking the Amyloid, Tau, and Mitochondrial Hypotheses of Alzheimer’s Disease and Identifying Promising Drug Targets
by: Zdeněk Fišar
Published: (2022-11-01)

Different Amyloid-β Self-Assemblies Have Distinct Effects on Intracellular Tau Aggregation
by: Woo Shik Shin, et al.
Published: (2019-11-01)

The Evidence for the Spread and Seeding Capacities of the Mutant Huntingtin Protein in in Vitro Systems and Their Therapeutic Implications
by: Maria Masnata, et al.
Published: (2017-11-01)

J Proteins Counteract Amyloid Propagation and Toxicity in Yeast
by: Daniel C. Masison, et al.
Published: (2022-08-01)

Amyloid β-protein oligomers promote the uptake of tau fibril seeds potentiating intracellular tau aggregation
by: Woo Shik Shin, et al.
Published: (2019-10-01)

Elecsys CSF biomarker immunoassays demonstrate concordance with amyloid-PET imaging
by: James D. Doecke, et al.
Published: (2020-03-01)

It's complicated: The relationship between sleep and Alzheimer's disease in humans
by: Brendan P. Lucey
Published: (2020-10-01)

The Mechanisms of the Roles of α-Synuclein, Amyloid-β, and Tau Protein in the Lewy Body Diseases: Pathogenesis, Early Detection, and Therapeutics
by: Moeko Noguchi-Shinohara, et al.
Published: (2023-06-01)

Amyloid and Tau Protein Concentrations in Children with Meningitis and Encephalitis
by: Artur Sulik, et al.
Published: (2022-03-01)

AMPA-ergic regulation of amyloid-β levels in an Alzheimer’s disease mouse model
by: Jane C. Hettinger, et al.
Published: (2018-05-01)

Amyloid, tau, pathogen infection and antimicrobial protection in Alzheimer’s disease –conformist, nonconformist, and realistic prospects for AD pathogenesis
by: Hongmei Li, et al.
Published: (2018-12-01)

Whole-brain modeling of the differential influences of amyloid-beta and tau in Alzheimer’s disease
by: Gustavo Patow, et al.
Published: (2023-12-01)